Investor List:

Top Therapeutics Pre-Seed Investors (186)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Alex Davidov, General Partner at Abstract Ventures
Alex Davidov
Abstract Ventures·General Partner
Sweet spot: $500K
Range: $250K - $750K
Investors in San Francisco (CA)
Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in Insurance (Pre-seed), Investors in Insurance (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in BioTech (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in BioTech (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in FinTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Seed), Investors in Insurance (Seed), Investors in Insurance (Seed), Investors in Web3/Blockchain (Seed), Investors in Web3/Crypto (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Dave Morin, Managing Partner at Offline Ventures
Dave Morin
Offline Ventures·Managing Partner
Sweet spot: $1M
Range: $500K - $5.0M
Investors in SF Bay Area (CA), Investors in California
Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in BioTech (Pre-seed), Investors in Social Networks (Pre-seed), Investors in BioTech (Pre-seed), Investors in Social Networks (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in AI (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in Space (Seed), Investors in EnergyTech (Seed), Investors in DeepTech (Seed), Investors in Robotics (Seed), Investors in EnergyTech (Seed), Investors in Web3/Crypto (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Social Networks (Seed), Investors in Social Networks (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Alexander Hall-Daniels, Associate at IndieBio
Alexander Hall-Daniels
IndieBio·Associate
Sweet spot: $525K
Range: $275K - $525K
Investors in United States, Investors in New York
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Robotics (Pre-seed), Investors in Hardware (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Seed), Investors in Hardware (Seed), Investors in Therapeutics (Seed), Investors in Robotics (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Therapeutics (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Hardware (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series B), Investors in Hardware (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Robotics (Series B), Investors in Therapeutics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Ketan Yerneni, Principal at KdT Ventures
Ketan Yerneni
KdT Ventures·Principal
Sweet spot: $850K
Range: $750K - $1M
Investors in Chicago (IL)
Investors in Therapeutics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Midwest (Other Lists)
Photo of Zdenek Fred Fous, General Partner at PurposeTech
Zdenek Fred Fous
PurposeTech·General Partner
Sweet spot: $100K
Range: $100K - $200K
Investors in Europe
Photo of Faisal Al Hammadi, Managing Partner at Further Ventures
Faisal Al Hammadi
Further Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Middle East
Investors in Therapeutics (Pre-seed), Investors in LegalTech (Pre-seed), Investors in ConstructionTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Supply Chain Tech (Pre-seed), Investors in MarketingTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in FinTech (Pre-seed), Investors in Therapeutics (Seed), Investors in LegalTech (Seed), Investors in Supply Chain Tech (Seed), Investors in ConstructionTech (Seed), Investors in Pharmaceuticals (Seed), Investors in MarketingTech (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in FinTech (Seed)
Photo of Thomas Schulz, Managing Partner at healthetia
Thomas Schulz
healthetia·Managing Partner
Sweet spot: $25K
Range: $10K - $100K
Investors in Europe, Investors in Austria, Investors in Germany, Investors in Switzerland